Search results
How to solve the weight loss drug shortage, according to a top Eli Lilly executive
Quartz· 2 hours agoloss pill for Eli Lilly to finally meet demand for its popular anti-obesity medications, according...
What the results of Wegovy’s longest clinical trial yet show about weight loss, side effects and...
CNN via Yahoo News· 2 days agoNew analyses of the longest clinical trial yet of the weight-loss drug Wegovy are shedding light on...
5 weight-loss drug stocks to watch as Ozempic, Zepbound sales surge
Bankrate via AOL· 7 days agoThe first GLP-1 drug was Byetta (exenatide), approved in 2005 for type 2 diabetes...
Eli Lilly reaches settlement with spa selling Mounjaro, Zepbound knockoffs
Reuters via AOL· 13 hours agoAs part of the deal, Totality Medispa will make a monetary payment to Lilly and will no longer use ...
Mounjaro vs. Ozempic: Which Is Better for Weight Loss?
MediaFeed via AOL· 2 days agoIn one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable...
Is Eli Lilly Stock A Buy Or A Sell As FDA Plans Meeting To Discuss Alzheimer's Drug?
Investor's Business Daily· 6 days agoLilly has proposed patients stop receiving the drug once their brains are clear of beta amyloid....
Lilly Settles With Spa Selling Mounjaro, Zepbound Knock-Offs
The Wall Street Journal· 15 hours agoEli Lilly has reached its first legal settlement with one of the spas that it had accused in...
If at First Tirzepatide Doesn't Succeed, Keep Trying
Medscape· 5 days agoWhen using tirzepatide (Zepbound, Eli Lilly) to treat obesity, patience may pay off. New post hoc data from Lilly' ...
Wegovy users keep weight off for four years, Novo Nordisk study says
Reuters via Yahoo News· 1 day agoLONDON (Reuters) -Patients taking Novo Nordisk's Wegovy obesity treatment maintained an average of...
Is Eli Lilly's Latest Deal a Gamechanger? | The Motley Fool
The Motley Fool· 24 hours agoEli Lilly (LLY 0.10%) is another rising star in the weight loss arena thanks to blockbuster drug